Lodoxamide significantly reduced tryptase levels ( P < 0.01 ) , neutrophils ( P < 0.04 ) , and eosinophils ( P < 0.01 ) in the tear fluid and significantly inhibited ocular itching ( P < 0.02 ) when compared with that of placebo .
